Bio-Techne
TECH
#1486
Rank
โ‚ฌ11.21 B
Marketcap
70,59ย โ‚ฌ
Share price
2.49%
Change (1 day)
-0.03%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.57 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are โ‚ฌ0.57 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚ฌ0.61 B8.81%
2022-06-30โ‚ฌ0.56 B-2.2%
2021-06-30โ‚ฌ0.58 B1.13%
2020-06-30โ‚ฌ0.57 B-8.94%
2019-06-30โ‚ฌ0.63 B43.67%
2018-06-30โ‚ฌ0.43 B-17.41%
2017-06-30โ‚ฌ0.53 B136.48%
2016-06-30โ‚ฌ0.22 B16.64%
2015-06-30โ‚ฌ0.19 B291.4%
2014-06-30โ‚ฌ49.26 M58.05%
2013-06-30โ‚ฌ31.17 M-12.08%
2012-06-30โ‚ฌ35.45 M62.73%
2011-06-30โ‚ฌ21.78 M56.53%
2010-06-30โ‚ฌ13.91 M25.89%
2009-06-30โ‚ฌ11.05 M-13.95%
2008-06-30โ‚ฌ12.85 M0.46%
2007-06-30โ‚ฌ12.79 M-45.79%
2006-06-30โ‚ฌ23.59 M4.15%
2005-06-30โ‚ฌ22.65 M-1.54%
2004-06-30โ‚ฌ23 M-1.28%
2003-06-30โ‚ฌ23.3 M-27.11%
2002-06-30โ‚ฌ31.97 M-28.25%
2001-06-30โ‚ฌ44.56 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚ฌ49.45 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.00 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.29 B 5,155.90%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.27 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.64 B 358.71%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
โ‚ฌ103.80 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ28.6 M-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA